Werewolf Therapeutics Inc (HOWL) Price Prediction & ForecastHOWLForecastWerewolf Therapeutics Inc

Alphio's HOWL stock price prediction model matches the current Werewolf Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.81 (-13.83%). The 1-week path is $0.81 (-13.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Werewolf Therapeutics Inc is a good buy right now, primarily due to its recent turnaround with a net profit of $3.67 million in Q2 2026, compared to a loss of $17.98 million in the same quarter last year, and a significant 167.15% increase in the 20-day change. The merger with Ambros Therapeutics, which includes a $150 million oversubscribed private placement, adds strong financial backing and market potential for the company's clinical developments. However, the main risk is the high insider selling activity, which has increased by 194.65% over the last month, indicating potential concerns among insiders about the company's future performance.

Werewolf Therapeutics Inc (HOWL) last closed at $0.9433, losing -2.83%. These facts feed the 1-day and 1-week HOWL price prediction above.